Atinumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | RTN4 |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 1226761-65-4 |
| ATC code | None |
| UNII | 9UBQ62RW32 |
| Chemical data | |
| Formula | ? |
| |
|
Atinumab is an immunomodulator. It binds to reticulon 4.[1]
References
- ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information 24 (4).
|
|||||||||||||||||||||||||||||||||||||||||||||
| This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
